Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by Alliancebernstein L.P.

Alliancebernstein L.P. lessened its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 14.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,261,483 shares of the company's stock after selling 206,037 shares during the period. Alliancebernstein L.P. owned about 0.48% of Ryan Specialty worth $80,937,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of Ryan Specialty by 5.7% during the 4th quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company's stock valued at $633,933,000 after purchasing an additional 529,631 shares during the last quarter. State Street Corp grew its position in shares of Ryan Specialty by 1.5% during the 3rd quarter. State Street Corp now owns 3,273,093 shares of the company's stock worth $217,301,000 after buying an additional 49,198 shares in the last quarter. Blair William & Co. IL increased its position in Ryan Specialty by 0.6% during the 4th quarter. Blair William & Co. IL now owns 2,765,963 shares of the company's stock valued at $177,464,000 after purchasing an additional 16,540 shares during the period. Principal Financial Group Inc. raised its stake in Ryan Specialty by 115.2% in the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock worth $117,619,000 after buying an additional 981,505 shares in the last quarter. Finally, Barclays PLC lifted its stake in shares of Ryan Specialty by 1.1% during the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company's stock worth $108,994,000 after purchasing an additional 17,267 shares during the last quarter. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Ryan Specialty Price Performance

NYSE:RYAN traded up $2.06 during trading hours on Tuesday, hitting $70.55. 289,825 shares of the stock were exchanged, compared to its average volume of 999,943. The firm's fifty day moving average price is $69.67 and its 200 day moving average price is $68.72. Ryan Specialty Holdings, Inc. has a 52-week low of $48.48 and a 52-week high of $77.16. The company has a market cap of $18.48 billion, a P/E ratio of 102.35, a P/E/G ratio of 1.19 and a beta of 0.66. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). The business had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. As a group, equities research analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were paid a $0.12 dividend. The ex-dividend date of this dividend was Tuesday, March 4th. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.68%. Ryan Specialty's dividend payout ratio (DPR) is 69.57%.

Analyst Upgrades and Downgrades

A number of research firms recently commented on RYAN. Keefe, Bruyette & Woods decreased their target price on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating for the company in a research report on Friday, February 21st. Wells Fargo & Company upped their target price on Ryan Specialty from $64.00 to $69.00 and gave the company an "equal weight" rating in a research report on Friday, February 21st. Royal Bank of Canada lowered their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a report on Friday, February 21st. Finally, UBS Group raised their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. One analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $75.27.

Insider Transactions at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 29,466 shares of the business's stock in a transaction dated Monday, January 13th. The shares were sold at an average price of $65.06, for a total value of $1,917,057.96. Following the sale, the director now directly owns 45,409 shares in the company, valued at approximately $2,954,309.54. The trade was a 39.35 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 241,360 shares of company stock worth $16,006,428 in the last quarter. Company insiders own 11.10% of the company's stock.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.